AXOVANT SCIENCES LTD ORD(NYSE:AXON) announced the earnings results for Fiscal Year 2017 and Q3. The results came in during After-Market on Feb 14, 2017. Based on the corporate Earnings and Guidance, many Investment Banking firms balance their portfolio to Sell and Buy Stocks based on their strategy of investing in stocks.Earnings per share were $-0.48. The reported EPS was below estimates by -6.67%. Analysts had estimated an EPS of $-0.45.
In a different note, Cowen & Co. said it Initiates Coverage On AXOVANT SCIENCES LTD ORD, according to a research note issued on Feb 3, 2017. The shares have been rated ‘Outperform’ by the firm.
AXOVANT SCIENCES LTD ORD (AXON) shares turned negative on Wednesdays trading session with the shares closing down -0.01 points or -0.08% at a volume of 4,84,778. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $12.215. The peak price level was also seen at $12.215 while the days lowest was $12.01. Finally the shares closed at $12.1. The 52-week high of the shares is $17.66 while the 52-week low is $10.69. According to the latest information available, the market cap of the company is $1,200 M.
Several Insider Transactions has been reported to the SEC. On Mar 14, 2016, Mark Altmeyer (Pres&Chief Commercial Officer) purchased 2,300 shares at $11.14 per share price.